This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hsu, S.-M. Articles by Whang-Peng, J. Search for Related Content PubMed PubMed Citation Articles by Hsu, S.-M. Articles by Whang-Peng, J.

Establishment of Human Mesothelioma Cell Lines (MS-1, -2) and Production of a Monoclonal Antibody (Anti-MS) with Diagnostic and Therapeutic Potential

Department of Pathology [S-M. H., P-L. H., X. Z.], University of Texas Health Science Center at Houston, Houston, Texas 77225, and Cytogenetic Oncology Section [C. S. K-S., J. W-P.], Medicine Branch, National Cancer Institute, Bethesda, Maryland 20205

We have established and characterized two mesothelioma cell lines, MS-1 and MS-2, in four attempts at long-term culture of these cells. Both MS-1 and MS-2 cells consistently express cytokeratin and vimentin, and both have long, slender microvilli. The cells that grew indefinitely (MS-1, MS-2) had a higher DNA index and a higher nucleus:cytoplasm ratio than did those cells that failed to grow (MS-3, MS-4). All mesothelioma cells, both in short- and in long-term culture, responded to phorbol ester induction by displaying morphological differentiation, such as an increase in the number of microvilli. The distribution of vimentin and cytokeratin in the cells, however, remained the same regardless of the growth pattern or the phorbol-ester treatment of the cells. We have used MS-1 cells to produce a monoclonal antibody (anti-MS) that reacts with mesothelioma cells, but rarely with reactive or normal mesothelial cells or with cells of normal tissues. The antibody does not induce the modulation of antigen, and it causes no direct or complement-mediated cytotoxicity of MS-1 or MS-2 cells. If a toxin or an isotope conjugate of the antibody is used, it may be valuable in the near future to test it for use in immunoimaging or immunotherapy.

¹ To whom requests for reprints should be addressed, at Department of Pathology, P. O. Box 20708, University of Texas, Health Sciences Center, Houston, TX 77225.

Received 6/22/87. Revised 3/24/88. Revised 6/ 6/88. Accepted 6/14/88.

This article has been cited by other articles:

				L. You, B. He, K. Uematsu, Z. Xu, J. Mazieres, A. Lee, F. McCormick, and D. M. Jablons Inhibition of Wnt-1 Signaling Induces Apoptosis in {beta}-Catenin-Deficient Mesothelioma Cells Cancer Res., May 15, 2004; 64(10): 3474 - 3478. [Abstract] [Full Text] [PDF]

				C.-T. Yang, L. You, K. Uematsu, C.-C. Yeh, F. McCormick, and D. M. Jablons p14ARF Modulates the Cytolytic Effect of ONYX-015 in Mesothelioma Cells with Wild-type p53 Cancer Res., August 1, 2001; 61(16): 5959 - 5963. [Abstract] [Full Text] [PDF]